DocGo Earnings Call Transcripts
Fiscal Year 2026
-
A leading mobile healthcare provider is scaling rapidly, leveraging proprietary technology and vertical integration to deliver in-home and virtual care, medical transportation, and remote monitoring. With strong financial guidance, record service volumes, and a focus on value-based care, the company is positioned for continued growth and industry leadership.
-
A leading mobile health and transport provider is shifting focus to high-growth mobile health services and commercial payers, while integrating a major telehealth acquisition. Record demand in medical transport is driving direct hiring and operational improvements. 2026 guidance targets 20% organic growth, with M&A focused on strategic capabilities.
Fiscal Year 2025
-
Q4 2025 revenue exceeded expectations at $74.9M, but adjusted EBITDA loss was $11.6M due to non-recurring costs. 2026 guidance was raised, with revenue expected at $290M-$310M and adjusted EBITDA loss narrowed to $5M-$10M, driven by growth in SteadyMD and medical transportation.
-
A tech-driven mobile healthcare provider highlighted strong revenue growth, expanding partnerships with payers and hospital systems, and a vertically integrated model. Recent acquisition of SteadyMD enhances efficiency and supports expansion, with guidance of $280–$300 million in revenue next year.
-
The company is expanding its tech-driven mobile healthcare and transportation services, with steady growth in core businesses and a strong balance sheet. Recent acquisitions enhance virtual care and last-mile delivery, while future growth is focused on recurring healthcare contracts and M&A opportunities.
-
Record Q3 base business growth offset the wind-down of migrant projects, with medical transportation and remote patient monitoring segments showing strong performance. The SteadyMD acquisition expands virtual care, and 2026 guidance projects 12–20% base business growth and improving margins.
-
The acquisition combines in-home and virtual care platforms, enabling nationwide scale, efficiency, and cross-selling opportunities. Expected synergies include up to 10% gross margin improvement and significant G&A savings, with integration targeted within six months. The deal positions the combined entity to address care gaps and primary care shortages while enhancing operational efficiency.
-
Mobile health and medical transportation are expanding rapidly, driven by tech integration, long-term contracts, and a shift to population health management. Growth is supported by aggressive hiring, targeted M&A, and a focus on underserved markets, with a strong emphasis on value-based care and operational efficiency.
-
Significant growth is driven by technology-enabled medical transportation and mobile health services, with nearly 1 million patients served annually and strong expansion into new markets. Mobile health is rapidly scaling, focusing on care gap closure and value-based care, while government contracts shift toward long-term population health programs.
-
A tech-driven mobile health and transport provider is expanding its core business, focusing on in-home care and non-emergency transport, with strong financials and a proprietary platform. Growth is driven by payer partnerships, care gap closure, and high barriers to entry.
-
Q2 2025 saw revenue decline due to the wind-down of migrant-related projects, but strong cash flow, reduced SG&A, and new contract wins improved the balance sheet. Medical Transportation grew as a share of revenue, and operational milestones were achieved, positioning for future growth.
-
A tech-driven mobile healthcare provider is scaling rapidly, leveraging proprietary technology and vertical integration to deliver in-home care and medical transportation. With strong financial resources, major new contracts, and a growing recurring revenue base, it targets a vast, underserved market and is positioned for continued growth.
-
The meeting covered board elections, executive compensation, and strategic growth plans, with all director nominees and the auditor ratified, but two proposed charter amendments not approved. Leadership highlighted a decade of growth, major milestones, and a focus on scalable, technology-driven healthcare delivery.
-
Mobile healthcare and medical transportation operations are expanding through technology-driven partnerships with hospitals and payers. Growth is fueled by new contracts, geographic expansion, and a rapidly scaling in-home care business, with a focus on efficiency and recurring revenue opportunities.
-
2025 guidance was revised down due to uncertainty in the government population health vertical, with core medical transportation and payer-provider businesses maintaining strong growth. Despite a Q1 net loss and lower revenue, positive cash flow and a robust balance sheet support ongoing investment and expansion.
-
A large mobile healthcare provider is winding down its migrant contract, expecting $50M in 2025 revenue and timely receivables. The payer business is expanding via home visits and tech, aiming for primary care and risk-based models. Medical transportation is stable and growing, while municipal efforts shift to population health.
-
The discussion highlighted strong financial results, significant investments in care gap closure, and a strategic shift from migrant contracts to population health programs. Technology and customer-driven expansion underpin growth, while high patient satisfaction and value-based care drive positive outcomes.
-
A leading mobile healthcare provider is expanding across hospital, payer, and municipal segments, leveraging technology and a value-based care approach. The payer business is set to double, with high patient satisfaction and a focus on underserved populations.
Fiscal Year 2024
-
Q4 2024 results reflected a sharp revenue decline due to the wind-down of migrant contracts, but base business and transport segments showed resilience. Aggressive investments in tech, personnel, and new service lines are expected to drive long-term growth, with 2025 guidance projecting stable margins and strong cash flow.
-
A leading mobile healthcare provider detailed rapid growth, strong financials, and a proprietary tech-enabled model serving hospitals, insurers, and municipalities. Expansion is driven by demand for in-home care, with a focus on preventative services and value-based partnerships.
-
Q3 saw $138.7M in revenue and $17.9M in adjusted EBITDA, with strong care gap program growth and improved margins. 2024 guidance was refined, with higher migrant-related revenue offset by lower non-migrant health, and 2025 guidance reflects ongoing investments and margin normalization.
-
A leading mobile healthcare provider is shifting focus from a major municipal contract to rapid expansion in payer-driven in-home care, leveraging technology and vertical integration for efficient scaling. Financial guidance projects strong revenue growth, margin improvement, and robust cash flow.
-
Mobile healthcare operations are scaling rapidly, with strong revenue growth, expanding market presence, and a proprietary tech platform driving efficiency. In-home care and medical transport services reduce hospital readmissions and costs, while value-based care and tech integration position the business for continued expansion and industry leadership.
-
A technology-driven mobile healthcare provider reported strong Q2 results, with $165 million in revenue and $6 million net income, and expects core business growth as migrant-related revenue phases out. Municipal contracts and preventative care drive recurring revenue, supported by proprietary technology and a strong balance sheet.
-
Q2 revenue grew over 30% year-over-year, with strong cash flow and a robust pipeline across hospital, municipal, and payer channels. Migrant-related revenue is winding down, while focus shifts to sustainable population health programs and in-home care gap closure, supporting ambitious 2024 growth targets.
-
Q2 2024 saw 31% revenue growth and strong cash flow, with operational execution driving margin improvement and new contract wins. Guidance for 2024 cash flow from operations was raised, and the company is expanding in mobile health and transportation while winding down migrant-related projects.
-
The meeting covered board elections, executive compensation, and auditor ratification, with all proposals approved. Strong 2023 and Q1 2024 results were highlighted, alongside strategic growth in insurance, hospital, and municipal health services. Innovation and technology remain central to future plans.
-
A leading mobile healthcare provider detailed its mission, recent contract transitions, and future growth plans. Migrant-related revenue is being phased out, with a focus on expanding core services and leveraging technology to target $400 million in base business for 2025.